Publications

Cisbani, G, TB Freeman, D Soulet, Saint Pierre, D Gagnon, M Parent, RA Hauser, RA Barker, and F Cicchetti. 2013. “Striatal Allografts in Patients With Huntington’s Disease: Impact of Diminished Astrocytes and Vascularization on Graft Viability. Brain 2013;136(Pt 2):433-43..”

Fernandez, HH, A Vanagunas, P Odin, AJ Espay, RA Hauser, DG Standaert, K Chatamra, et al. 2013. “Levodopa-Carbidopa Intestinal Gel in Advanced Parkinson’s Disease Open-Label Study: Interim Results. Parkinsonism Relat Disord 2013;19:339-45.”. Parkinsonism Relat Disord.

Group. , Horizon Investigators of the Huntington Study. 2013. “A Randomized, Double-Blind, Placebo-Controlled Study of Latrepirdine in Patients With Mild to Moderate Huntington Disease. JAMA Neurol 2013;70:25-33.”. JAMA Neurol.

Hauser, RA, D Truong, J Hubble, C Coleman, JL Beffy, S Chang, and P Picaut. 2013. “AbobotulinumtoxinA (Dysport) Dosing in Cervical Dystonia: An Exploratory Analysis of Two Large Open-Label Extension Studies. J Neural Transm 2013;120:299-307.”. J Neural Transm.

AH, Schapira, P Barone, RA Hauser, Y Mizuno, O Rascol, M Busse, C Debieuvre, M Fraessdorf, and W Poewe. 2013. “Success Rate, Efficacy, and Safety/Tolerability of Overnight Switching from Immediate- to Extended-Release Pramipexole in Advanced Parkinson’s Disease. Eur J Neurol 2013;20:180-7.”. Eur J Neurol.

Schapira, AH, P Barone, RA Hauser, Y Mizuno, O Rascol, M Busse, C Debieuvre, M Fraessdorf, and W Poewe. 2013. “Patient-Reported Convenience of Once-Daily versus Three-Times-Daily Dosing During Long-Term Studies of Pramipexole in Early and Advanced Parkinson’s Disease. Eur J Neurol 2013;20:50-6.”. Eur J Neurol.

Hauser, RA, and DG Grosset. 2012. “SPECT Brain Imaging in Patients With Suspected Parkinsonian Syndromes.”. J Neuroimaging.

Hauser, RA, P Auinger, and Parkinson Study Group. 2012. “Determination of Minimal Clinically Important Change in Early and Advanced Parkinson’s Disease. Mov Disord 2011;26:813-8.”. Mov Disord.

Mizuno, Y, M Yamamoto, S Kuno, K Hasegawa, N Hattori, T Kagimura, A Sarashina, et al. 2012. “Pramipexole ER Study Group. Efficacy and Safety of Extended- versus Immediate-Release Pramipexole in Japanese Patients With Advanced and L-Dopa-Undertreated Parkinson Disease: A Double-Blind, Randomized Trial. Clin Neuropharmacol 2012;35:174-81.”. Clin Neuropharmacol.

Morelli, M, F Blandini, N Simola, and RA Hauser. 2012. “A(2A) Receptor Antagonism and Dyskinesia in Parkinson’s Disease. Parkinsons Dis 2012;1-8.”. Parkinsons Dis.